More evidence for unprotected left main PCI

Original title: Outcomes After Emergency Percutaneous Coronary Intervention in Patients UIT unprotected Left Main Stem Occlusion. The BCIS National Audit of Percutaneous Coronary Intervention 6-Years Experience. Reference: Niket Patel, et al. J Am Coll Cardiol Interv 2014;7:969-80

AMI involving unprotected left main is not frequent in catheterization labs since most of these cases present in shock. There is little information in the literature and follow up is scarce. Between January 2007 and December 2012 a total of 446,257 PCI procedures were registered at the British Cardiovascular Intervention Society.

All patients registered to primary PCI were analyzed; 568 of these patients presented unprotected left main stem occlusion, 1,045 presented non occlusive lesion and 97,974 had no left main compromise. 

Those with left main lesion were older, often women, diabetic and presented renal failure. The unprotected left main stem occlusion group presented reduced ejection fraction and cardiogenic shock. Time intervals from symptom onset to hospitalization and symptom onset to balloon were lower for those with left main occlusion. 

Femoral access, multi vessel PCI, mechanical respiratory assistance, pump support and hospitalization time were more frequent in the left main PCI group.  At hospital level, mortality was 6 times higher for those with left main lesion (26.4% vs 4.1% <0.001) and it was even higher in patients with left main occlusion vs. patients with non-occlusive lesions (43.3% vs. 20.6% <0.001).

Follow up at 1 and 3 years, mortality was higher in patients with left main compromise (39.8% and 60.4% vs. 9.8% and 20.7% respectively; p <0.001). 

Conclusion

Unprotected left main primary PCI outcomes are often poor and require additional therapies to be improved. However, long term outcomes in survivors are encouraging.

Commentary

Unprotected left main primary PCI is one of the worst scenarios we could face. It requires vast experience and fast action, with outcomes that are not auspicious. It is necessary to develop support circulatory systems as well as new drugs or strategies to obtain better results.

Corrtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation
Buenos Aires- Argentina

Carlos Fava

More articles by this author

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...